Perioperative Epidural Block and Dexamethasone in Pancreatic Cancer Surgery
Status:
Recruiting
Trial end date:
2026-07-01
Target enrollment:
Participant gender:
Summary
Pancreatic cancer remains a devastating disease with an average 5-year survival rate of about
3-5%. Previous retrospective studies showed that perioperative epidural block and/or
dexamethasone are associated with improved outcome after cancer surgery. This randomized
trial aims to investigate the effect of perioperative epidural block and/or dexamethasone on
long-term survival in patients following pancreatic cancer surgery.
Phase:
Phase 4
Details
Lead Sponsor:
Peking University First Hospital
Collaborators:
Beijing Cancer Hospital The Second Affiliated Hospital of Chongqing Medical University